×
About 3,585 results

ALLMedicine™ Upper Respiratory Tract Infection Center

Research & Reviews  938 results

Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Coliti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211104
Drug Design, Development and Therapy; Napolitano M, D'Amico F et. al.

Jun 25th, 2022 - Upadacitinib is a selective small molecule that inhibits Janus kinase (JAK) type 1. This molecule is administrated orally and is currently approved for the treatment of rheumatoid arthritis, atopic dermatitis, and psoriatic arthritis. Upadacitinib...

ProAir Digihaler in COPD Disease Management: A Real World Study
https://clinicaltrials.gov/ct2/show/NCT04821869

Jun 24th, 2022 - The trial is an unblinded open label single center study designed to identify trends in Peak Inspiratory Flow (PIF) rates and Rescue Albuterol Inhaler usage (Inhalations) that associate with disease deterioration as defined by worsening of symptom...

Potential and promising marker for serious bacterial infections in children: Delta neut...
https://doi.org/10.1111/jpc.16065
Journal of Paediatrics and Child Health; Yigit M, Ozkaya-Parlakay A et. al.

Jun 24th, 2022 - This study aimed to evaluate the usefulness and accuracy of the delta neutrophil index (DNI), an index expressing the number of immature granulocytes as a proportion of the total, as an inflammatory marker in predicting serious bacterial infection...

Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Sy...
https://doi.org/10.1159/000524199
Dermatology (Basel, Switzerland); Naik PP

Jun 14th, 2022 - Psoriasis is an immune-mediated protracted ailment that perturbs about 100 million people globally. Anti-interleukin (IL)-23 agents have a distinctive status of safety and clinical efficacy. Anti-IL-23 operatives have demonstrated therapeutic prom...

Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narc...
https://doi.org/10.5664/jcsm.10090
Journal of Clinical Sleep Medicine : JCSM : Official Publ... Lecendreux M, Plazzi G et. al.

Jun 12th, 2022 - Evaluate long-term efficacy and safety of sodium oxybate (SXB) in children and adolescents (aged 7-16 years) with narcolepsy with cataplexy. A double-blind randomized withdrawal study was conducted. Prior to randomization, SXB-naive participants w...

see more →

Guidelines  1 results

Clinical practice guideline for the diagnosis and management of acute bacterial sinusit...
https://doi.org/10.1542/peds.2013-1071
Pediatrics Wald ER, Applegate KE et. al.

Jun 26th, 2013 - To update the American Academy of Pediatrics clinical practice guideline regarding the diagnosis and management of acute bacterial sinusitis in children and adolescents. Analysis of the medical literature published since the last version of the gu...

see more →

Drugs  49 results see all →

Clinicaltrials.gov  103 results

ProAir Digihaler in COPD Disease Management: A Real World Study
https://clinicaltrials.gov/ct2/show/NCT04821869

Jun 24th, 2022 - The trial is an unblinded open label single center study designed to identify trends in Peak Inspiratory Flow (PIF) rates and Rescue Albuterol Inhaler usage (Inhalations) that associate with disease deterioration as defined by worsening of symptom...

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children
https://clinicaltrials.gov/ct2/show/NCT05381363

May 19th, 2022 - This project aims to improve the treatment of pediatric patients infected with COVID-19. Interferon has antiviral property and is approved to be used in treatment in hepatitis B and hepatitis C virus infections. Interferon α2b, β1a and lambda are ...

The Effect of Lavender Oil Inhalation on Pain, Anxiety and Sleep Quality After Coronary Artery Bypass Graft
https://clinicaltrials.gov/ct2/show/NCT05377983

May 17th, 2022 - The study is a non-drug clinical, randomized controlled study, and will be conducted in the Cardiovascular Surgery Clinic of Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi associated to Istanbul Provincial Directorate of Health between Dece...

Preoperative Aspirin and Benzydamine Hydrochloride Gargles on Severity and Duration of Post-Operative Sore Throat
https://clinicaltrials.gov/ct2/show/NCT05343429

May 12th, 2022 - Endotracheal intubation commonly causes postoperative sore throat (POST). Its incidence is 22 - 62% in the adult population whereas in children the incidence is 24 to 44%. In adult population peak incidence is 2 to 4 hours after tracheal extubatio...

Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection
https://clinicaltrials.gov/ct2/show/NCT04930900

May 4th, 2022 - This is a Phase 1, single-dose, two-period study that will consist of a combined screening and baseline period and an open-label treatment period. Subjects will be enrolled when they experience an Upper Respiratory Tract Infection with nasal conge...

see more →

News  342 results

Large integrated safety analysis reinforces known safety profile of ixekizumab in PsA
https://www.mdedge.com/dermatology/article/254006/psoriatic-arthritis/large-integrated-safety-analysis-reinforces-known

Apr 25th, 2022 - Key clinical point: Ixekizumab demonstrated an overall consistent safety and tolerability profile with no unexpected/new adverse events (AE) in patients with psoriatic arthritis (PsA) and up to 3 years of exposure to ixekizumab. Major finding: Tre.

Angioimmunoblastic T-cell Lymphoma Mimicking DRESS Syndrome
https://www.mdedge.com/dermatology/article/253247/urticaria/angioimmunoblastic-t-cell-lymphoma-mimicking-dress-syndrome
Morgan Keefe, DO, MPH, Talayesa Buntinx-Krieg, MD et. al.

Mar 29th, 2022 - Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive lymphoma arising from follicular T-helper cells that predominantly affects older adults and carries a 5-year overall survival rate of 32%. 1 Notably, as many as 50% of AITL patients.

Avapritinib Approved in Europe for Advanced Systemic Mastocytosis
https://www.onclive.com/view/avapritinib-approved-in-europe-for-advanced-systemic-mastocytosis

Mar 25th, 2022 - The European Commission has expanded the current indication for avapritinib (Ayvakyt) to include use as a single agent in adult patients with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, or mast ...

FDA Approves Generic Symbicort for Asthma, COPD
https://www.medscape.com/viewarticle/970360

Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...

Second CAR T-Cell Therapy Approved for Myeloma
https://www.medpagetoday.com/hematologyoncology/myeloma/97437

Mar 1st, 2022 - The FDA approved ciltacabtagene autoleucel (cilta-cel; Carvykti), the second chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed or refractory multiple myeloma, Janssen Pharmaceuticals announced. Ciltacabtagene autoleucel, a B-...

see more →

Patient Education  1 results see all →